Figure 4

Box plots of immune cell components and CYT score comparison between timing of cancer recurrence in TCGA BC cohort. (A) Anti-cancer immune cells, (B) pro-cancerous immune cells, and C, CYT scores were shown. Primary BCs with cancer recurrence data were analyzed and categorized as follows: recurrence ≤2 years (Early), recurrence between 2–5 years (Mid), recurrence >5 years (Late), and no recurrence >5 years (Survivors). **Means P < 0.01 and *means P < 0.05. Abbreviations: CYT, immune cytolytic activity; TCGA, The Cancer Genome Atlas; BC, breast cancer; K-W, Kruskal-Wallis; NS, not significant.